Intellia Therapeutics (NTLA)
(Delayed Data from NSDQ)
$22.44 USD
-0.56 (-2.43%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $22.44 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth F Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/14/2024
Time: -- |
9/2024 | $-1.38 | 0.41% |
Earnings Summary
For their last quarter, Intellia Therapeutics (NTLA) reported earnings of -$1.31 per share, missing the Zacks Consensus Estimate of -$1.21 per share. This reflects a negative earnings surprise of 8.26%. Look out for NTLA's next earnings release expected on November 14, 2024. For the next earning release, we expect the company to report earnings of -$1.38 per share, reflecting no change in earnings compared to the year-ago quarter.
Earnings History
Price & Consensus
Zacks News for NTLA
Intellia Therapeutics, Inc. (NTLA) Reports Q2 Loss, Lags Revenue Estimates
NTLA: What are Zacks experts saying now?
Zacks Private Portfolio Services